e-Clinical Avatars and Personalized Medicine Disease Networks

Author:

Sanjeev Wadhwa

Given the thousands of clinical trials currently underway, and the incalculable billions of dollars of funding already spent, the pharma industry cannot possibly test all combinations on large patient populations for patients to see any benefits in their lifetime. The traditional clinical trial model fails as diseases like cancer and Alzheimer’s tend to be multi-factorial in nature, with molecular and phenotypic differentiation causing patient-level differences in effectiveness.

A new approach in R&D innovation will come from genomically-enabled, semantically-interoperable, patient-centric collaborative disease networks of interconnected clinical research community, research based institutions, investigator networks, CROs, pharma, research informatics networks like CaBIG, providers, patients, labs and payers.

Download "e-Clinical Avatars and Personalized Medicine Disease Networks" (PDF, 3020KB)

For more information, please contact us.